AstraZeneca completes $2 billion equity investment in Summit Therapeutics
AstraZeneca completed a $2 billion equity investment in Summit Therapeutics.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
AstraZeneca Completes $2 Billion Equity Investment in Summit Therapeutics
Summit Therapeutics announced the successful closing of AstraZeneca’s strategic equity investment of $2 billion in Summit. The investment will accelerate the development of ivonescimab.